| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 11, 2023 | Jan 13, 2023 | FATE THERAPEUTICS INC | Director | Buy | 97.5 | +124,679 | 78.87% | ✗ | $698.1K |
| Jun 3, 2022 | Jun 6, 2022 | FATE THERAPEUTICS INC | Director | Sell | 36.3 | -1,364 | -0.86% | ✗ | $31.1K |
| Mar 10, 2022 | Mar 11, 2022 | FATE THERAPEUTICS INC | Director | Sell | 15.0 | -31,562 | -16.52% | ✓ | $1.1M |
| Dec 20, 2018 | Dec 26, 2018 | aTYR PHARMA INC | Director | Buy | 95.0 | +245,000 | 66.15% | ✗ | $103.2K |
| Aug 31, 2017 | Sep 5, 2017 | aTYR PHARMA INC | CEO | Buy | 95.0 | +37,736 | 11.43% | ✗ | $100K |
| Apr 24, 2017 | Apr 26, 2017 | aTYR PHARMA INC | CEO | Buy | 47.5 | +124 | 0.04% | ✓ | $372 |
| Apr 18, 2017 | Apr 20, 2017 | aTYR PHARMA INC | CEO | Buy | 67.5 | +2,552 | 0.79% | ✓ | $7.7K |
| Dec 19, 2016 | Dec 21, 2016 | aTYR PHARMA INC | CEO | Buy | 95.0 | +69,000 | 26.96% | ✗ | $151.7K |
| Apr 5, 2016 | Apr 7, 2016 | aTYR PHARMA INC | CEO | Buy | 77.5 | +2,500 | 1.01% | ✗ | $8.8K |
| Apr 5, 2016 | Apr 6, 2016 | aTYR PHARMA INC | CEO | Buy | 77.5 | +2,500 | 1.02% | ✗ | $8.9K |
| Oct 4, 2013 | Oct 7, 2013 | FATE THERAPEUTICS INC | Director | Buy | 95.0 | +16,667 | 11.90% | ✗ | $100K |